MENU

Cellma Haematology EHR for Integrated NHS Blood Disorder Services

Haematology services across the NHS and global healthcare systems manage complex diagnostic pathways, urgent referrals for blood cancer, long-term management of chronic blood disorder conditions, and time-critical transfusion safety processes. Rising demand for sickle cell disease management, haemophilia services, and rapid diagnostics in acute leukaemia requires more than a generic system. It requires a purpose-built Haematology EHR.



The Cellma Haematology EHR connects referrals, clinics, day units, transfusion services, and oncology pathways into one interoperable digital platform. Consultants, specialist nurses, and laboratory teams gain structured, accessible haematology health records at every stage of care.



With national focus on Blood Cancer Waiting Times and recovery targets under NHS England, real-time visibility of diagnostics, chemotherapy scheduling, and coagulation monitoring is essential. Cellma integrates these elements to create a secure scalable haematology electronic patient record (EPR) tailored for NHS haematology services.

Aligned with NHS 10-Year Plan:

Cellma is purpose-built to support these goals through prevention-focused, digitally enabled, and integrated community care.

Core Features of the Cellma Haematology EHR

Structured Haematology
Records

The use of standardised templates across both benign and malignant haematology pathways provides an ability for clinicians to capture complete and continuous digital records of referrals, investigations, treatment plans, and survivorship using NICE and NHS standards.

Integrated Coagulation Monitoring System

Enables INR tracking, clotting factor records, anticoagulation alerts, and standardised haemophilia templates for safe NHS care.

Blood Cancer Tracking
Platform

Tracks staging, chemotherapy cycles, biopsies, and molecular diagnostics, with structured workflows for leukaemia and lymphoma pathways aligned to national cancer standards.

Management of Sickle
Cell Disease

Specialised modules capture notes from harmful episodes, track transfusion history, prescribe pain management plans, and track follow-up across Integrated Care Systems.

Templates for Care Pathway of Hemophilia

Use of structured templates for treatment with factor replacement therapy, logs of bleeding, prophylactic prescriptions, and monitoring of at-home therapies will improve results from treatment for hemophilia over the long-term.

Integration of Transfusion and
Laboratory Processes

Seamless integration between anatomy and laboratory transfusion processes provides real-time laboratory data exchange, enhancing the safety of managing blood products and increasing the accuracy of diagnosis.

Telemedicine and Virtual Care for
Hematology

Use of built-in virtual clinic functionality allows for synchronous telehealth consultations, remote monitoring of patient status, and secure asynchronous communication.

AI-Enabled Clinical Decision
Support

AI-enabled workflows analyse structured data to flag abnormal lab trends, highlight high-risk blood cancer cases, and assist prioritisation of urgent referrals. Predictive analytics also support capacity planning and pathway management.

Integration of Transfusion and
Laboratory Processes

Designed for high-level interoperability, Cellma integrates with PAS, GP Connect, Spine services, imaging platforms, chemotherapy prescribing systems, and shared care records using HL7 and FHIR standards.

Security and Compliance with Standards

Aligned with GDPR, NHS Digital, and CQC governance requirements, Cellma includes role-based access control, audit trails, and encryption protocols to protect patient data across NHS environments.

Why NHS Teams Choose Cellma Haematology EHR

  • Structured Haematology EMR ensures consistent blood disorder documentation. 
  • Real-time coagulation monitoring dashboards support safer anticoagulation care. 
  • Integrated blood cancer pathways improve visibility of diagnostics and treatment. 
  • AI-driven clinical alerts help prioritise high-risk cases. 
  • Telemedicine tools enable secure virtual haematology clinics. 
  • Patient portal access supports remote engagement and follow-up. 
  • Interoperability across PAS, pathology, GP Connect, and Spine enables coordinated NHS care. 
  • Robust security aligned with NHS Digital and CQC protects patient data.

Why NHS Teams Choose Cellma Haematology EHR

  • Fully compliant with NHS Digital & CQC standards

  • SNOMED CT, HL7, and FHIR supported Interoperability models

  • Integrated blood cancer & coagulation workflows

  • Templates available for both structured and Non-structured 
haemophilia/sickle cell
  • Real-time BI dashboards for NHS performance monitoring

  • Compatible with all of the NHS Innovation Accelerator/SBRI funding pathways

  • Supports NHS Long Term Plan digital transformation objectives

  • Secure and reliable deployment across NHS and global infrastructure

Results with Cellma Haematology EHR

How Cellma Haematology EHR Supports the Future of Blood Disorder Care

Integrated Haematology Pathways within ICS

By connecting referrals, outpatient services, day units, transfusion services and community follow-ups through one integrated and seamless record, Cellma reduces fragmentation and provides shared visibility for managing complex blood disorders across an Integrated Care System (ICS).

Enhanced Interoperability and Secure Data Sharing

Designed with high-level interoperability, Cellma can provide secure data transfer between acute hospitals, specialties, community services, GP Connect and Spine.. Clinicians access consistent and up-to-date haematology health records at every stage of care.

Predictive and Performance-Driven Haematology Care

Predictive analytics support blood cancer capacity planning, urgent referral prioritisation, and pathway optimisation. Real-time dashboards provide ICS-level oversight of patient outcomes, transfusion safety, and haemophilia and sickle cell service performance.

Integration with NHS Systems and Global Digital Infrastructure

Cellma is built for interoperability, ensuring smooth integration with national and international healthcare systems: 

UK Healthcare Integration 

Fully aligned with the NHS 10 Year Plan, supporting its vision for integrated, patient-centred, and digitally enabled care over the next decade. 

Global Healthcare Integration 

Built for global healthcare, enabling connected, patient-centred, and digital-first care anywhere in the world. 

This ensures that Cellma is not only NHS-compliant but also adaptable to global digital health infrastructures, making it a future-ready choice for healthcare providers anywhere. 

Frequently Asked Questions (FAQs)

How does Cellma haematology EHR support NHS haematology departments?
Cellma provides structured digital records, integrated coagulation monitoring, blood cancer tracking, transfusion safety oversight, and full interoperability with PAS, GP Connect, and Spine. It aligns with NHS Digital and CQC standards to support safe and compliant care delivery.
Can Cellma support blood cancer management and leukaemia pathways?
Yes. Cellma includes a dedicated blood cancer tracking platform with staging documentation, chemotherapy cycle management, molecular diagnostics recording, and structured workflows for leukaemia management in line with NHS cancer standards.
Does Cellma support sickle cell disease and haemophilia care?
Yes. Cellma includes specialist templates for sickle cell crisis documentation, transfusion tracking, factor replacement therapy, and long-term haemophilia monitoring across Integrated Care Systems.